Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Robarts Research Institute, |
RCV000660675 | SCV000782829 | likely benign | Hypercholesterolemia, familial, 1 | 2018-01-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003303092 | SCV004000634 | uncertain significance | Cardiovascular phenotype | 2023-05-18 | criteria provided, single submitter | clinical testing | The p.V770I variant (also known as c.2308G>A), located in coding exon 16 of the APOB gene, results from a G to A substitution at nucleotide position 2308. The valine at codon 770 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |